ask="32.00"
ask_size="500"
average_daily_volume="411197"
bid="30.00"
bid_size="1300"
book_value="6.09"
change="+1.48"
change_from_200_day_moving_average="-0.07"
change_from_50_day_moving_average="5.00"
change_from_52_week_high="-11.52"
change_From_52_week_low="7.50"
change_in_percent="+5.16%"
close="30.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.77"
ebitda="-60.77M"
eps_estimate_current_year="-1.93"
eps_estimate_next_quarter="-0.57"
eps_estimate_next_year="-1.75"
ex_dividend_date="N/A"
float_shares="31497000"
high="32.57"
high_52_weeks="41.69"
last_trade_date="3/2/2017"
last_trade_price="30.17"
last_trade_size="24770"
last_trade_time="4:00pm"
low="29.35"
low_52_weeks="22.67"
market_capitalization="1.14B"
moving_average_200_day="30.24"
moving_average_50_day="25.17"
name="Acceleron Pharma Inc."
notes="N/A"
one_year_target_price="43.89"
open="30.11"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.24%"
percent_change_from_50_day_moving_average="+19.86%"
percent_change_from_52_week_high="-27.63%"
percent_change_from_52_week_low="+33.08%"
previous_close="28.69"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.71"
price_per_sales="38.40"
revenue="28.21M"
shares_outstanding="37746000"
short_ratio="6.51"
stock_exchange="NGM"
symbol="XLRN"
volume="1209327"
weeks_range_52="22.67 - 41.69"
